# Temasek Holdings' Biotech Investments: 30 Startups in Its Portfolio (2026) > The 30 Biotech startups Temasek Holdings has backed, by stage: $6.1B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/temasek-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 16 - [Guardant Health](https://millionrounds.com/company/guardant-health) - [*WN* WuXi NextCODE](https://millionrounds.com/company/wuxi-nextcode) - [Innovent Biologics](https://millionrounds.com/company/innovent-biologics) - [Orchard Therapeutics](https://millionrounds.com/company/orchard-therapeutics) - [Abogen Biosciences](https://millionrounds.com/company/abogen-biosciences) - [*O* Oviva](https://millionrounds.com/company/oviva) - [Pear Therapeutics](https://millionrounds.com/company/pear-therapeutics) - [*I* Innovent](https://millionrounds.com/company/innovent) - [*SB* SQZ Biotechnologies](https://millionrounds.com/company/sqz-biotechnologies) - [*B* BioVex](https://millionrounds.com/company/biovex) - [Akili Interactive Labs](https://millionrounds.com/company/akili-interactive-labs) - [Visterra](https://millionrounds.com/company/visterra) - [Cambridge Epigenetix](https://millionrounds.com/company/cambridge-epigenetix) - [Arterys](https://millionrounds.com/company/arterys) - [Allay Therapeutics](https://millionrounds.com/company/allay-therapeutics) - [The EVERY Company](https://millionrounds.com/company/the-every-company) ## Series B 8 - [*VB* Viela Bio](https://millionrounds.com/company/viela-bio) - [Solugen](https://millionrounds.com/company/solugen) - [JW Therapeutics](https://millionrounds.com/company/jw-therapeutics) - [Gracell Biotechnologies](https://millionrounds.com/company/gracell-biotechnologies) - [Homology Medicines](https://millionrounds.com/company/homology-medicines) - [D3 Bio](https://millionrounds.com/company/d3-bio) - [AllinMD](https://millionrounds.com/company/allinmd) - [SQZ Biotech](https://millionrounds.com/company/sqz-biotech) ## Stage not reported 3 - [*VL* Verily Life Sciences](https://millionrounds.com/company/verily-life-sciences) - [Living Carbon](https://millionrounds.com/company/living-carbon) - [Glympse Bio](https://millionrounds.com/company/glympse-bio) ## Series A 3 - [Samsara Eco](https://millionrounds.com/company/samsara-eco) - [Locana](https://millionrounds.com/company/locana) - [*M* Medisix](https://millionrounds.com/company/medisix) ## Segment by segment ### Series C and later 16 startups · $3.8B raised - [**Guardant Health**](https://millionrounds.com/company/guardant-health) Guardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data. United States $800M - [*WN* **WuXi NextCODE**](https://millionrounds.com/company/wuxi-nextcode) United States $515M - [**Innovent Biologics**](https://millionrounds.com/company/innovent-biologics) Established in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for China $385M - [**Orchard Therapeutics**](https://millionrounds.com/company/orchard-therapeutics) Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies. United Kingdom $377M - [**Abogen Biosciences**](https://millionrounds.com/company/abogen-biosciences) Abogen Biosciences is a clinical-stage biotechnology company focused on RNA-based medicines, particularly in mRNA science and technology. China $300M - [*O* **Oviva**](https://millionrounds.com/company/oviva) Switzerland $246M - [**Pear Therapeutics**](https://millionrounds.com/company/pear-therapeutics) Pear Therapeutics is a Massachusetts-based prescription digital therapeutic platform that offers solutions such as clinical engage United States $239M - [*I* **Innovent**](https://millionrounds.com/company/innovent) Hong Kong SAR China $150M ### Series B 8 startups · $1.3B raised - [*VB* **Viela Bio**](https://millionrounds.com/company/viela-bio) Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. United States $325M - [**Solugen**](https://millionrounds.com/company/solugen) Discover the realm of digital intimacy where connections transcend physical boundaries. United States $246M - [**JW Therapeutics**](https://millionrounds.com/company/jw-therapeutics) JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment. China $190M - [**Gracell Biotechnologies**](https://millionrounds.com/company/gracell-biotechnologies) Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. China $185M - [**Homology Medicines**](https://millionrounds.com/company/homology-medicines) Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases. United States $144M - [**D3 Bio**](https://millionrounds.com/company/d3-bio) D3 Bio is a clinical-stage biotechnology company based in Wuxi, China, founded in 2020. China $108M - [**AllinMD**](https://millionrounds.com/company/allinmd) AllinMD is a medical platform for orthopedic surgeons. China $100M - [**SQZ Biotech**](https://millionrounds.com/company/sqz-biotech) SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells. United States $23M ### Stage not reported 3 startups · $882M raised - [*VL* **Verily Life Sciences**](https://millionrounds.com/company/verily-life-sciences) United States $800M - [**Living Carbon**](https://millionrounds.com/company/living-carbon) Living Carbon is a public benefit corporation based in Hayward, California, founded in 2019. United States $42M - [**Glympse Bio**](https://millionrounds.com/company/glympse-bio) Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response. United States $40M ### Series A 3 startups · $142M raised - [**Samsara Eco**](https://millionrounds.com/company/samsara-eco) Samsara Eco is an Australian biotechnology and environmental-tech company based in Sydney, specializing in enzymatic recycling technology. Australia $67M - [**Locana**](https://millionrounds.com/company/locana) Locana is a location and mapping technology company that provides geospatial solutions and applications. United States $55M - [*M* **Medisix**](https://millionrounds.com/company/medisix) Singapore $20M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Temasek Holdings as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Temasek Holdings' AI portfolio** 42 startups · $184B](https://millionrounds.com/portfolio-maps/temasek-ai-portfolio)[Sector portfolio **Temasek Holdings' Fintech portfolio** 18 startups · $7.1B](https://millionrounds.com/portfolio-maps/temasek-fintech-portfolio)[Sector portfolio **Temasek Holdings' Agtech portfolio** 12 startups · $1.5B](https://millionrounds.com/portfolio-maps/temasek-agtech-portfolio)[Sector portfolio **Temasek Holdings' Energy portfolio** 11 startups · $8.4B](https://millionrounds.com/portfolio-maps/temasek-energy-portfolio)[Co-investors **Who invests with Temasek Holdings** 292 co-investors](https://millionrounds.com/portfolio-maps/temasek-co-investors)[Portfolio map **Temasek Holdings portfolio map** 170 startups · $279B](https://millionrounds.com/portfolio-maps/temasek-portfolio-map) ## Raising from investors like Temasek Holdings? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)